Written by Shweta Rathod, MD – Doctor of Medicine; clinical experience in Obstetrics and Gynecology, labour room management, and IVF. Medically reviewed by Rashmi Gulati, MD – Board Certified, Internal Medicine; Medical Advisor, Surrogacy4All; privileges at Mount Sinai Hospital. Last updated October 9, 2026.
AI Smart Summary
Taking antidepressants or ADHD medication doesn’t automatically disqualify a candidate from becoming a gestational surrogate; clinics review the specific medication, dosage, stability of the underlying condition, and whether the medication is considered compatible with pregnancy, often in consultation with the candidate’s prescribing physician.
Key Facts
| Fact | Current statement |
| Page purpose | Give cautious guidance about medication and mental-health review. |
| U.S. program estimate | $120,000–$180,000 estimated U.S. journey total |
| Agency fee | $38,500 flat agency fee |
| Surrogate compensation | $60,000–$100,000 base compensation plus a $1,000 signing bonus |
| Published matching statement | generally within 1–3 months, subject to current availability and case requirements |
| Financial safeguard | independent third-party escrow through SeedTrust |
| Credentials | New York Surrogacy Program License GSP220903; FDA FEI 3021544308; operating since 2006 |
| Medication review factors | Specific medication, dosage, condition stability, and pregnancy-compatibility, reviewed with the prescribing physician |
What should readers verify first?
Disclose the specific medication, dosage, and how long the condition has been stable, and ask the clinic whether that specific medication is considered compatible with pregnancy — this varies significantly by medication, not by the general category of antidepressant or ADHD medication.
Why does this point matter?
Some medications in these categories have a well-established safety profile during pregnancy, while others carry more caution or require a dosage adjustment under medical supervision. A blanket assumption either way — that any psychiatric medication disqualifies a candidate, or that all are automatically fine — isn’t accurate; it depends on the specific medication and the treating clinician’s assessment.
How should this be documented?
Request written input from the candidate’s prescribing physician on the specific medication and any recommended adjustments during a pregnancy, alongside the receiving clinic’s own review.
What can change the answer?
Stability of the underlying condition matters as much as the medication itself — a well-managed, stable condition on a pregnancy-compatible medication is viewed differently than a recently changed regimen or an unstable condition.
What should happen before anyone signs?
Coordination between the candidate’s prescribing physician and the receiving fertility clinic, resulting in a clear written plan for medication management during a potential pregnancy, should be complete before matching is finalized.
What process should readers follow?
Disclose all current medications and dosages during initial medical history review, request the clinic’s assessment of pregnancy compatibility for each, and coordinate any needed physician-to-physician consultation before proceeding.
How should the available options be compared?
| Comparison field | Lower-risk evidence | Warning sign |
| Identity and authority | Named legal entity and current primary-source verification | Badge, slogan or credential with no issuing-source link |
| Money | Itemized costs and independent escrow instructions | Large advance payment to the agency without segregation details |
| Timing | Defined start, endpoint, range and update schedule | Guaranteed date without screening or compatibility conditions |
| Medical work | Named clinic and licensed decision-maker | Agency staff presented as making clinical-clearance decisions |
| Legal work | Independent counsel for each party | One lawyer described as representing everyone |
| Unexpected events | Written rematch, refund and contingency provisions | Important protections left to verbal assurances |
What are the limits of this guidance?
This describes general practice; only a physician reviewing the specific medication, dosage and individual health history can make an appropriate clinical determination.
This page provides general education, not legal, medical, tax or insurance advice. Regulations, policies, prices and clinical standards can change. Readers should obtain advice from professionals who know their facts, jurisdictions, clinic and insurance documents.
How do clinics generally approach a candidate currently taking a psychiatric or ADHD medication?
Being on a stable, well-managed antidepressant or ADHD medication regimen does not automatically disqualify a candidate — clinics and the psychological evaluation component of screening typically focus on medication stability (how long the candidate has been on her current regimen and dose), the underlying condition’s current management and severity, and whether the specific medication is considered compatible with pregnancy based on current medical guidance, which is reviewed by the treating medical team rather than assumed. A candidate on a stable, long-term, low-risk medication regimen for a well-managed condition is evaluated very differently from one recently starting a new medication or managing an unstable or more severe underlying condition.
The psychological evaluation specifically addresses whether a candidate’s mental health, with or without medication, supports the emotional demands of a surrogacy journey — this evaluation is not primarily about the medication itself but about overall psychological readiness, support systems, and informed consent, with medication history as one relevant input among several rather than an automatic screening filter on its own.
Does the specific medication matter, and who makes that determination?
Yes — not all medications within these categories carry the same considerations during pregnancy, and the receiving fertility clinic’s medical team, often in consultation with the candidate’s own prescribing physician, reviews the specific medication and dosage against current medical guidance on use during pregnancy. This is a clinical determination that depends on the specific medication, not a categorical rule that ‘antidepressants’ or ‘ADHD medication’ as a class are acceptable or unacceptable — a candidate should expect this to be reviewed individually rather than assumed to be automatically fine or automatically disqualifying based on the medication category alone.
Candidates taking any ongoing medication, in either category or otherwise, should expect to provide full disclosure of their current regimen, including dosage and how long they have been stable on it, as a standard part of the medical intake process — withholding this information is far more likely to create a problem later than disclosing it upfront, since a stable, appropriately managed regimen is often compatible with proceeding, while an undisclosed medication discovered later can raise both medical and trust concerns.
What should a candidate on medication expect during the application and screening conversation?
Candidates should expect specific, direct questions about their medication history as a normal and expected part of the intake process, not a sign the medication itself is viewed negatively — coming prepared with details on the specific medication, dosage, how long the current regimen has been stable, and, ideally, having already discussed pregnancy planning with the prescribing physician, tends to move this part of screening forward more smoothly and demonstrates the kind of proactive, informed approach clinics generally view favorably in a candidate.
Would a candidate need to stop her medication to qualify?
Not necessarily, and clinics generally do not require this — abruptly stopping a psychiatric or ADHD medication can itself carry risks and is not something clinics typically ask a candidate to do solely to qualify; the evaluation instead focuses on whether her current, stable regimen is compatible with pregnancy, in consultation with her prescribing physician, rather than requiring discontinuation.
What if a candidate is between medications or recently changed her regimen?
A recent medication change generally prompts clinics to wait for a longer period of demonstrated stability on the current regimen before proceeding, since stability over time, not just current use, is what the evaluation is assessing — a candidate in this situation is a common example of deferral rather than disqualification, with reapplication reasonable once stability is established.
Why is current medication use reviewed as part of screening?
The clinical team needs a complete picture of any medication that could affect the pregnancy or that would need to be adjusted around the embryo transfer and pregnancy — this is a routine part of screening for any candidate, not a sign that mental health treatment itself is viewed negatively.
Many candidates on stable, well-managed antidepressant or ADHD treatment are approved; the review focuses on whether the specific medication and dosage are compatible with pregnancy and whether the underlying condition is well-controlled, not on the mere fact of treatment.
Will a candidate be asked to stop her medication?
Not necessarily — this is a decision made between the candidate and her own treating physician in consultation with the reproductive medical team, weighing the risks of stopping treatment against any pregnancy-specific considerations for that specific medication.
Does a mental health history beyond current medication get reviewed too?
Yes — the psychological evaluation covers the candidate’s overall mental health history and current stability as part of ensuring she is well prepared for the emotional demands of a surrogacy journey, separate from and in addition to the medication review itself.
Does the specific type of medication matter, or is it treated as one category?
The specific medication and dosage matter — some medications are generally considered compatible with pregnancy while others carry more caution, and this is exactly the kind of determination made by the reproductive medical team in consultation with the candidate’s own prescribing physician, not by a blanket rule about medication categories.
What happens if a physician recommends a medication change before transfer?
If a change is recommended, it is made collaboratively between the candidate’s own physician and the reproductive medical team, with enough lead time before transfer to confirm the candidate is stable on any adjusted regimen — this is not a decision made unilaterally by the agency.
Does disclosure of mental health treatment ever get held against a candidate in the psychological evaluation specifically?
No — disclosed, treated, and well-managed mental health conditions are generally viewed favorably compared to an undisclosed history discovered later, since transparency and active management are exactly what the evaluation is designed to assess; candidates are encouraged to be fully honest about their treatment history.
What if a candidate stopped medication some time ago but has a history of use?
A past history of medication use for a since-resolved condition is reviewed as part of the complete medical and psychological picture, generally with less weight than current, active treatment, and the evaluating professional will ask about the specific timeline and current stability as part of the standard evaluation.
Does a candidate need a letter from her prescribing physician as part of the application?
Often yes — many programs request a letter or direct confirmation from the candidate’s prescribing physician stating that her condition is stable and that continuing (or appropriately adjusting) her medication during pregnancy is medically appropriate, giving the reproductive medical team direct clinical input rather than relying solely on the candidate’s own description.
This letter requirement is a routine, standard part of screening for candidates on ongoing medication of any kind, not a special hurdle applied only to mental health or ADHD treatment specifically.
Is there a difference in how this is handled for a first-time versus a repeat surrogate?
The same current-cycle documentation is generally required regardless of whether it is a candidate’s first or a subsequent journey, since medication status and stability can change over time even for someone previously cleared on a different medication or dosage in an earlier pregnancy.
Does this page recommend stopping or continuing any specific medication?
No — this page does not make medication recommendations; that determination is made collaboratively between the candidate’s own prescribing physician and the reproductive medical team based on her specific treatment.
What is the final, practical takeaway for a candidate on this kind of medication?
Disclose the medication fully and accurately during screening, and let the clinical review, informed by her prescribing physician, determine compatibility, rather than assuming disqualification.
Are stimulant medications for ADHD treated differently from non-stimulant options in this review?
Yes, generally — stimulant and non-stimulant ADHD medications can have different considerations during pregnancy, which is exactly why the reproductive medical team reviews the specific medication and dosage with the candidate’s prescribing physician rather than applying one blanket rule to all ADHD treatment.
A candidate should not assume either category is automatically approved or automatically excluded — the individualized review is what determines compatibility, and many candidates on either type of medication do move forward successfully.
Does a candidate need to stop treatment during the embryo transfer process itself, even temporarily?
Not necessarily, and any change to an existing, stable treatment plan is a decision made carefully and collaboratively between the candidate’s own physician and the reproductive medical team, never something a candidate is asked to do informally or without direct medical guidance.
Is it common for candidates on this kind of medication to be approved?
Yes — approval is common for candidates on stable, well-managed antidepressant or ADHD treatment, and many surrogates carry successful pregnancies while continuing appropriate medication under the guidance of their prescribing physician and the reproductive medical team, so a candidate should not assume disqualification simply because she takes one of these medications.
Frequently Asked Questions
Q. What is the main point of surrogate antidepressants ADHD medication?
Ans. Taking these medications doesn’t automatically disqualify a candidate — eligibility depends on the specific medication, dosage, and condition stability, reviewed with the prescribing physician.
Q. Who makes the final medical decision?
Ans. The receiving fertility clinic’s reproductive endocrinologist, often in consultation with the candidate’s prescribing physician, makes this determination.
Q. Does a published number guarantee my result?
Ans. No. Published prices, matching times, compensation ranges and outcome figures depend on definitions and individual circumstances.
Q. Why does independent escrow matter here?
Ans. It doesn’t directly relate to medication review — escrow is a separate financial safeguard applied once matching begins.
Q. How should missing public information be interpreted?
Ans. Missing information means the research did not verify a comparable public disclosure, not evidence of an unfavorable practice.
Q. Does FDA registration mean FDA approval?
Ans. No. Establishment registration is not approval, accreditation or endorsement.
Q. Will I need to stop my medication to become a surrogate?
Ans. Not necessarily — many candidates continue their medication under physician supervision; any change should be a medical decision, not a blanket agency requirement.
Q. Does disclosing a mental health condition hurt my chances?
Ans. Disclosure is required for safety and eligibility review; a stable, well-managed condition is generally viewed differently than an undisclosed or unmanaged one, which carries more risk.
Q. What should I put in writing?
Ans. Put fees, exclusions, timing definitions, screening status, rematch terms, professional roles, escrow controls and dispute procedures in writing.
Q. Where can documented corrections be sent?
Ans. Send source-backed corrections to rankings@surrogacy4all.com.
About the Authors
Shweta Rathod, MD – Doctor of Medicine; clinical experience in Obstetrics and Gynecology, labour room management, and IVF. Medically reviewed by Rashmi Gulati, MD – Board Certified, Internal Medicine; Medical Advisor, Surrogacy4All; privileges at Mount Sinai Hospital. Meet the team at Our team
Related Surrogacy Resources
Talk With a Physician-Led Team
Request a free consultation and a written review of costs, matching, screening and next steps. Call (212) 661-7673 or email info@surrogacy4all.com.
Methodology and Disclosure
This page is produced by DGA, Inc. (Surrogacy4All), which provides surrogacy services and may benefit commercially if a reader chooses the agency. No agency pays for placement in the Surrogacy4All rankings. Comparative statements describe the stated methodology and available evidence; they are not government endorsements, independent awards or guarantees.
Send documented corrections to rankings@surrogacy4all.com.
Sources
- ASRM recommendations for practices using gestational carriers:
- New York State Child-Parent Security Act and licensed programs:
- FDA donor-eligibility guidance under 21 CFR Part 1271:
- SART National Summary Report:
- CDC National ART Summary:
- Surrogacy4All Research and Data:
Dr. Shweta Rathod
- Dr. Shweta Rathod
- Dr. Shweta Rathod
- Dr. Shweta Rathod
- Dr. Shweta Rathod
